IL155071A0 - Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same - Google Patents

Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same

Info

Publication number: IL155071A0
Authority: IL; Israel
Prior art keywords: same; compositions containing; medical compositions; glucopyranosyloxybenzylbenzene derivatives; glucopyranosyloxybenzylbenzene
Prior art date: 2000-09-29

Application number

IL15507101A

Other languages

English (en)

Original Assignee

Kissei Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-29

Filing date

2001-09-21

Publication date

2003-10-31

2001-09-21 Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical

2003-10-31 Publication of IL155071A0 publication Critical patent/IL155071A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Hematology (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

IL15507101A 2000-09-29 2001-09-21 Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same IL155071A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000301523		2000-09-29
PCT/JP2001/008239 WO2002028872A1 (fr)	2000-09-29	2001-09-21	Derives de glucopyranosiloxybenzylbenzene et compositions therapeutiques contenant ces composes

Publications (1)

Publication Number	Publication Date
IL155071A0 true IL155071A0 (en)	2003-10-31

Family

ID=18783054

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15507101A IL155071A0 (en)	2000-09-29	2001-09-21	Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
IL155071A IL155071A (en)	2000-09-29	2003-03-25	Glucopyranosyloxybenzylbenzene derivatives, uses thereof and pharmaceutical compositions containing the same

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL155071A IL155071A (en)	2000-09-29	2003-03-25	Glucopyranosyloxybenzylbenzene derivatives, uses thereof and pharmaceutical compositions containing the same

Country Status (32)

Country	Link
US (2)	US6872706B2 (zh)
EP (1)	EP1329456B1 (zh)
JP (1)	JP3798375B2 (zh)
KR (1)	KR100647204B1 (zh)
CN (1)	CN1293087C (zh)
AR (1)	AR030816A1 (zh)
AT (1)	ATE335753T1 (zh)
AU (2)	AU2001290257B2 (zh)
BG (1)	BG66015B1 (zh)
BR (1)	BR0114310A (zh)
CA (1)	CA2423568C (zh)
CY (1)	CY1106076T1 (zh)
CZ (1)	CZ303544B6 (zh)
DE (1)	DE60122193T2 (zh)
DK (1)	DK1329456T3 (zh)
EA (1)	EA005994B1 (zh)
ES (1)	ES2269456T3 (zh)
HU (1)	HUP0301178A3 (zh)
IL (2)	IL155071A0 (zh)
MX (1)	MXPA03002779A (zh)
MY (1)	MY129023A (zh)
NO (1)	NO327182B1 (zh)
NZ (1)	NZ524917A (zh)
PE (1)	PE20020476A1 (zh)
PL (1)	PL205607B1 (zh)
PT (1)	PT1329456E (zh)
SI (1)	SI1329456T1 (zh)
SK (1)	SK287811B6 (zh)
TW (1)	TWI284641B (zh)
UA (1)	UA73606C2 (zh)
WO (1)	WO2002028872A1 (zh)
ZA (1)	ZA200302283B (zh)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1020944C (zh)	1990-01-30	1993-05-26	阿图尔-费希尔股份公司费希尔厂	紧固件
IL155071A0 (en)	2000-09-29	2003-10-31	Kissei Pharmaceutical	Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
AU2002223127A1 (en) *	2000-11-30	2002-06-11	Kissei Pharmaceutical Co., Ltd. Intellectual Property	Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
TWI255817B (en)	2001-02-14	2006-06-01	Kissei Pharmaceutical	Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
PL210710B1 (pl) *	2002-03-22	2012-02-29	Kissei Pharmaceutical	Krystaliczne postaci 2-(4-metoksybenzylo) fenylo-6-O-etoksykarbonylo-ß-D-glukopiranozydu, ich zastosowanie oraz zawierająca je kompozycja farmaceutyczna
AU2003254903B9 (en) *	2002-08-09	2008-08-21	Taisho Pharmaceutical Co., Ltd.	Method for selective preparation of aryl 5-thio-beta-D-aldohexopyranosides
JP4651934B2 (ja) *	2002-12-04	2011-03-16	キッセイ薬品工業株式会社	ベンジルフェノール誘導体、それを含有する医薬組成物およびその医薬用途
CN1744916A (zh) *	2002-12-04	2006-03-08	橘生药品工业株式会社	预防和治疗高血糖所导致的疾病
DE10258007B4 (de) *	2002-12-12	2006-02-09	Sanofi-Aventis Deutschland Gmbh	Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
UA86042C2 (en) *	2003-08-01	2009-03-25	Янссен Фармацевтика Н.В.	Substituted indazole-o-glucosides
EP2360165A3 (de) *	2004-03-16	2012-01-04	Boehringer Ingelheim International GmbH	Glucopyranosyl-substituierte Benzol-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
JPWO2005095429A1 (ja) *	2004-03-31	2008-02-21	キッセイ薬品工業株式会社	フェノール誘導体、それを含有する医薬組成物及びその医薬用途
CA2572793C (en) *	2004-07-21	2015-11-03	Kissei Pharmaceutical Co., Ltd.	Progression inhibitor for disease attributed to abnormal accumulation of liver fat
TW200606129A (en)	2004-07-26	2006-02-16	Chugai Pharmaceutical Co Ltd	Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
JP2008524162A (ja) *	2004-12-16	2008-07-10	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	グルコピラノシル置換ベンゼン誘導体、該化合物を含む薬物、その使用及びその製造方法
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP5073948B2 (ja) *	2005-01-31	2012-11-14	田辺三菱製薬株式会社	医薬組成物
DE602006009772D1 (de) *	2005-02-23	2009-11-26	Boehringer Ingelheim Int	Glucopyranosylsubstituierte ((hetero)arylethynyl-benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose-cotransporters typ 2 (sglt2)
CA2605245A1 (en) *	2005-04-15	2006-10-19	Boehringer Ingelheim International Gmbh	Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
US7723309B2 (en) *	2005-05-03	2010-05-25	Boehringer Ingelheim International Gmbh	Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
UA91546C2 (uk) *	2005-05-03	2010-08-10	Бьорінгер Інгельхайм Інтернаціональ Гмбх	КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en)	2005-05-10	2010-08-10	Boehringer Ingelheim International Gmbh	Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
TW200733966A (en) *	2005-07-27	2007-09-16	Boehringer Ingelheim Int	Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
CA2620566A1 (en) *	2005-08-30	2007-03-08	Boehringer Ingelheim International Gmbh	Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
RU2008113050A (ru) *	2005-09-08	2009-10-20	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-(4-ЭТИНИЛБЕНЗИН)-БЕНЗОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
AR056195A1 (es) *	2005-09-15	2007-09-26	Boehringer Ingelheim Int	Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
EP1989191B1 (en) *	2006-02-15	2011-07-20	Boehringer Ingelheim International GmbH	Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
PE20080697A1 (es)	2006-05-03	2008-08-05	Boehringer Ingelheim Int	Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
DE102006028862A1 (de)	2006-06-23	2007-12-27	Merck Patent Gmbh	3-Amino-imidazo[1,2-a]pyridinderivate
TW200817424A (en)	2006-08-04	2008-04-16	Daiichi Sankyo Co Ltd	Benzylphenyl glucopyranoside derivatives
US20080109178A1 (en) *	2006-11-03	2008-05-08	Nikon Corporation	Method and system for predicting and correcting signal fluctuations of an interferometric measuring apparatus
MY157365A (en)	2006-12-06	2016-05-31	Smithkline Beecham Corp	Chemical compounds and uses
DE102007008420A1 (de)	2007-02-21	2008-08-28	Merck Patent Gmbh	Benzimidazolderivate
CL2008002427A1 (es) *	2007-08-16	2009-09-11	Boehringer Ingelheim Int	Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
DE102007048716A1 (de)	2007-10-11	2009-04-23	Merck Patent Gmbh	Imidazo[1,2-a]pyrimidinderivate
CL2008003653A1 (es)	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
WO2009096503A1 (ja) *	2008-01-31	2009-08-06	Daiichi Sankyo Company, Limited	ベンジルフェニルグルコピラノシド誘導体
DE102008017590A1 (de)	2008-04-07	2009-10-08	Merck Patent Gmbh	Glucopyranosidderivate
WO2010009243A1 (en)	2008-07-15	2010-01-21	Theracos, Inc.	Deuterated benzylbenzene derivatives and methods of use
WO2010023594A1 (en) *	2008-08-28	2010-03-04	Pfizer Inc.	Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
BRPI1013640A2 (pt)	2009-02-13	2019-09-24	Boehringer Ingelheim International Gmbh	composicao farmaceutica, metodos para o tratamento e usos dos mesmos
CN102307577A (zh)	2009-02-13	2012-01-04	贝林格尔.英格海姆国际有限公司	包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
WO2010092126A1 (en) *	2009-02-13	2010-08-19	Boehringer Ingelheim International Gmbh	Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
JP5736377B2 (ja) *	2009-09-30	2015-06-17	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	１−クロロ−４−（β−Ｄ−グルコピラノス−１−イル）−２−［４−（（Ｓ）−テトラヒドロフラン−３−イルオキシ）ベンジル］ベンゼンの結晶形の調製方法
PT2486029E (pt) *	2009-09-30	2015-10-14	Boehringer Ingelheim Int	Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
UY32919A (es) *	2009-10-02	2011-04-29	Boehringer Ingelheim Int	Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
AU2010309788A1 (en)	2009-10-20	2012-04-05	Novartis Ag	Glycoside derivative and uses thereof
CA2777857C (en)	2009-11-02	2014-12-02	Pfizer Inc.	Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
AR079438A1 (es)	2009-12-09	2012-01-25	Panacea Biotec Ltd	Derivados de azucar, composiciones farmaceuticas y sus usos
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012025857A1 (en)	2010-08-23	2012-03-01	Hetero Research Foundation	Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
UY33937A (es)	2011-03-07	2012-09-28	Boehringer Ingelheim Int	Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
JP2014510782A (ja)	2011-04-14	2014-05-01	ノバルティスアーゲー	グリコシド誘導体およびその使用
US8614195B2 (en)	2011-04-14	2013-12-24	Novartis Ag	Glycoside derivatives and uses thereof
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US9192617B2 (en)	2012-03-20	2015-11-24	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
EP2774619B1 (de)	2013-03-04	2016-05-18	BioActive Food GmbH	Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
WO2014159452A1 (en)	2013-03-14	2014-10-02	Mars, Incorporated	Flavor composition containing hmg glucosides
US20140303098A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HK1213818A1 (zh)	2013-04-05	2016-07-15	勃林格殷格翰国际有限公司	依帕列净的治疗用途
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HUE058731T2 (hu)	2013-04-18	2022-09-28	Boehringer Ingelheim Int	Gyógyászati készítmények, kezelési eljárások és ezek alkalmazásai
EP2944311A1 (de)	2014-05-16	2015-11-18	BioActive Food GmbH	Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen
CN109922813A (zh)	2016-11-10	2019-06-21	勃林格殷格翰国际有限公司	药物组合物、治疗方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2549476B1 (fr)	1983-07-20	1986-04-25	Rech Ind	Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
CA2102591C (en) *	1992-11-12	2000-12-26	Kenji Tsujihara	Hypoglycemic agent
US5731292A (en)	1992-11-12	1998-03-24	Tanabe Seiyaku Co., Ltd.	Dihydrochalcone derivatives which are hypoglycemic agents
TR200202200T2 (tr) *	2000-03-17	2002-12-23	Kissei Pharmaceutical Co., Ltd.	Glükopiranosiloksibenzilbenzen türevleri, bu türevleri ihtiva eden tıbbi bileşimler ve türevlerin hazırlanması için ara-maddeler.
US6683056B2 (en)	2000-03-30	2004-01-27	Bristol-Myers Squibb Company	O-aryl glucoside SGLT2 inhibitors and method
IL155071A0 (en)	2000-09-29	2003-10-31	Kissei Pharmaceutical	Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same

2001
- 2001-09-21 IL IL15507101A patent/IL155071A0/xx unknown
- 2001-09-21 EA EA200300316A patent/EA005994B1/ru not_active IP Right Cessation
- 2001-09-21 CA CA2423568A patent/CA2423568C/en not_active Expired - Fee Related
- 2001-09-21 PT PT01970186T patent/PT1329456E/pt unknown
- 2001-09-21 SI SI200130638T patent/SI1329456T1/sl unknown
- 2001-09-21 KR KR1020037004588A patent/KR100647204B1/ko not_active Expired - Fee Related
- 2001-09-21 HU HU0301178A patent/HUP0301178A3/hu unknown
- 2001-09-21 SK SK334-2003A patent/SK287811B6/sk not_active IP Right Cessation
- 2001-09-21 JP JP2002532454A patent/JP3798375B2/ja not_active Expired - Fee Related
- 2001-09-21 ES ES01970186T patent/ES2269456T3/es not_active Expired - Lifetime
- 2001-09-21 BR BR0114310-7A patent/BR0114310A/pt not_active Application Discontinuation
- 2001-09-21 MX MXPA03002779A patent/MXPA03002779A/es active IP Right Grant
- 2001-09-21 EP EP01970186A patent/EP1329456B1/en not_active Expired - Lifetime
- 2001-09-21 NZ NZ524917A patent/NZ524917A/en not_active IP Right Cessation
- 2001-09-21 WO PCT/JP2001/008239 patent/WO2002028872A1/ja not_active Ceased
- 2001-09-21 AU AU2001290257A patent/AU2001290257B2/en not_active Ceased
- 2001-09-21 US US10/381,846 patent/US6872706B2/en not_active Expired - Lifetime
- 2001-09-21 AU AU9025701A patent/AU9025701A/xx active Pending
- 2001-09-21 AT AT01970186T patent/ATE335753T1/de active
- 2001-09-21 CZ CZ20030777A patent/CZ303544B6/cs not_active IP Right Cessation
- 2001-09-21 DK DK01970186T patent/DK1329456T3/da active
- 2001-09-21 UA UA2003032735A patent/UA73606C2/uk unknown
- 2001-09-21 CN CNB018165605A patent/CN1293087C/zh not_active Expired - Fee Related
- 2001-09-21 DE DE60122193T patent/DE60122193T2/de not_active Expired - Lifetime
- 2001-09-21 PL PL362177A patent/PL205607B1/pl not_active IP Right Cessation
- 2001-09-26 MY MYPI20014500A patent/MY129023A/en unknown
- 2001-09-28 AR ARP010104589A patent/AR030816A1/es unknown
- 2001-09-28 TW TW090124049A patent/TWI284641B/zh not_active IP Right Cessation
- 2001-09-28 PE PE2001000975A patent/PE20020476A1/es not_active Application Discontinuation
2003
- 2003-03-24 ZA ZA200302283A patent/ZA200302283B/en unknown
- 2003-03-25 IL IL155071A patent/IL155071A/en not_active IP Right Cessation
- 2003-03-26 BG BG107674A patent/BG66015B1/bg unknown
- 2003-03-27 NO NO20031407A patent/NO327182B1/no not_active IP Right Cessation
2004
- 2004-08-12 US US10/916,548 patent/US20050065098A1/en not_active Abandoned
2006
- 2006-11-01 CY CY20061101571T patent/CY1106076T1/el unknown

Also Published As

Publication number	Publication date
PL205607B1 (pl)	2010-05-31
PL362177A1 (en)	2004-10-18
NO20031407L (no)	2003-04-30
JP3798375B2 (ja)	2006-07-19
SK3342003A3 (en)	2003-08-05
PE20020476A1 (es)	2002-07-04
AR030816A1 (es)	2003-09-03
SK287811B6 (sk)	2011-10-04
EA005994B1 (ru)	2005-08-25
NO327182B1 (no)	2009-05-04
EP1329456A1 (en)	2003-07-23
MY129023A (en)	2007-03-30
US6872706B2 (en)	2005-03-29
NZ524917A (en)	2005-01-28
BG66015B1 (bg)	2010-10-29
CA2423568C (en)	2011-03-15
DK1329456T3 (da)	2006-12-04
EP1329456B1 (en)	2006-08-09
HK1061037A1 (zh)	2004-09-03
ZA200302283B (en)	2005-05-27
PT1329456E (pt)	2006-12-29
JPWO2002028872A1 (ja)	2004-02-12
DE60122193D1 (de)	2006-09-21
ATE335753T1 (de)	2006-09-15
US20040018998A1 (en)	2004-01-29
WO2002028872A1 (fr)	2002-04-11
MXPA03002779A (es)	2004-05-04
TWI284641B (en)	2007-08-01
BR0114310A (pt)	2003-10-14
US20050065098A1 (en)	2005-03-24
NO20031407D0 (no)	2003-03-27
BG107674A (bg)	2004-01-30
KR100647204B1 (ko)	2006-11-17
CN1293087C (zh)	2007-01-03
CN1466590A (zh)	2004-01-07
CZ303544B6 (cs)	2012-11-28
CY1106076T1 (el)	2011-06-08
AU9025701A (en)	2002-04-15
IL155071A (en)	2010-04-15
SI1329456T1 (sl)	2006-12-31
DE60122193T2 (de)	2007-07-05
EP1329456A4 (en)	2005-03-30
AU2001290257B2 (en)	2007-08-30
UA73606C2 (en)	2005-08-15
CA2423568A1 (en)	2002-04-11
EA200300316A1 (ru)	2003-08-28
HUP0301178A3 (en)	2009-08-28
KR20030036867A (ko)	2003-05-09
ES2269456T3 (es)	2007-04-01
HUP0301178A2 (hu)	2003-11-28

Publication	Publication Date	Title
IL155071A0 (en)	2003-10-31	Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
IL152451A0 (en)	2003-05-29	2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
IL153123A0 (en)	2003-06-24	N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
AU2001290257A1 (en)	2002-06-27	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en)	2003-05-01	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL161616A0 (en)	2004-09-27	Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158044A0 (en)	2004-03-28	Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL156558A0 (en)	2004-01-04	Novel quinuclidine derivatives and medicinal compositions containing the same
IL158300A0 (en)	2004-05-12	Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL151372A0 (en)	2003-04-10	Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
IL154747A0 (en)	2003-10-31	Pyrazole derivatives and pharmaceutical compositions containing the same
IL156369A0 (en)	2004-01-04	Pyrazole derivatives and pharmaceutical compositions containing the same
IL145757A0 (en)	2002-07-25	Pyrazole derivatives and pharmaceutical compositions containing the same
IL145756A0 (en)	2002-07-25	Pyrazole derivatives and pharmaceutical compositions containing the same
IL156354A0 (en)	2004-01-04	Pyridoindole derivatives and pharmaceutical compositions containing the same
IL158076A0 (en)	2004-03-28	Benzamidine derivatives and pharmaceutical compositions containing the same
IL152490A0 (en)	2003-05-29	Pyridine derivatives and pharmaceutical compositions containing the same
IL151952A0 (en)	2003-04-10	Aminopyridine derivatives and pharmaceutical compositions containing the same
IL155196A0 (en)	2003-11-23	Benzamide derivatives and pharmaceutical compositions containing the same
IL150734A0 (en)	2003-02-12	Azaindole derivatives and pharmaceutical compositions containing the same
IL158523A0 (en)	2004-05-12	Epothilone derivatives and pharmaceutical compositions containing the same
IL156812A0 (en)	2004-02-08	Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL152846A0 (en)	2003-06-24	Pyridazinone derivatives and pharmaceutical compositions containing the same
IL152094A0 (en)	2003-05-29	Ecteinascidin derivatives and pharmaceutical compositions containing the same
IL147214A0 (en)	2002-08-14	1-methylcarbapenem derivatives and pharmaceutical compositions containing the same